Skip to main content
. 2020 Jul 1;9(16):6069–6075. doi: 10.1002/cam4.3267

Figure 2.

Figure 2

Differences in neo‐adjuvant/adjuvant chemotherapy between MBC and FBC patients indicated for these therapies (N = 57,550) The left bar indicates the MBC group, and the right bar indicates the FBC group. Among stage II‐III patients who received surgery, MBC patients received chemotherapy less frequently than FBC patients in neo‐adjuvant or adjuvant settings (35.4% vs 54.0%; P < .001). MBC; male breast cancer, FBC; female breast cancer